A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.

Objective To estimate changes in healthcare spending in the US after implementation of the No Surprises Act (NSA) in 2022 ...

Increased use of neoadjuvant chemotherapy appeared associated with improvements in short-term mortality without sacrificing long-term survival in ovarian cancer, according to a comparative ...

As private equity firms continue to increase their ownership stake in various health care sectors in the US, questions arise about potential impacts on the organization and delivery of care. Using a ...

Patient care experiences worsened after private equity firms took over hospitals, according to a difference-in-differences analysis. From 2008 to 2019, the percentage of patients rating hospitals a 9 ...